NCT01946035View on ClinicalTrials.gov

Alpha-Blockers in Allergic Rhinitis (MAN 01)

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Allergic Rhinitis
Interventions
DRUG

Doxazosin XL

OTHER

Placebo

Trial Locations (1)

DD1 3AU

Brian Lipworth, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT01946035 - Alpha-Blockers in Allergic Rhinitis (MAN 01) | Biotech Hunter | Biotech Hunter